124 related articles for article (PubMed ID: 33275232)
1. MiR-20a suppresses proliferation and facilitates apoptosis of breast cancer cells via the MTOR signaling pathway.
Shi KY; Fan LY; Xu D; Ren LP; Wang LP; Chen LY; Wang LJ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11650-11657. PubMed ID: 33275232
[TBL] [Abstract][Full Text] [Related]
2. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R
Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245
[TBL] [Abstract][Full Text] [Related]
5. MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.
Hu Y; Zhu Q; Tang L
PLoS One; 2014; 9(3):e92099. PubMed ID: 24637915
[TBL] [Abstract][Full Text] [Related]
6. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
Zhang YM; Wu QM; Chang LY; Liu JC
Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
[TBL] [Abstract][Full Text] [Related]
7. MiR-125a-5p inhibits the proliferation and invasion of breast cancer cells and induces apoptosis by targeting GAB2.
Wang LB; Feng L; He J; Liu B; Sun JG
Math Biosci Eng; 2019 Jul; 16(6):6923-6933. PubMed ID: 31698596
[No Abstract] [Full Text] [Related]
8. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
[TBL] [Abstract][Full Text] [Related]
9. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway.
Zhu FY; Gan CW; Wang MX; Sun BC; Li FJ; Qiu YH; Wang K
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3717-3723. PubMed ID: 32329848
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
11. MiR-324/SOCS3 Axis Protects Against Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury and Regulates Myocardial Ischemia via TNF/NF-κB Signaling Pathway.
Han X; Chen X; Han J; Zhong Y; Li Q; An Y
Int Heart J; 2020 Nov; 61(6):1258-1269. PubMed ID: 33191336
[TBL] [Abstract][Full Text] [Related]
12. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
Liu S; Zhang Y; Huang C; Lin S
J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
[TBL] [Abstract][Full Text] [Related]
13. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
Wu SM; Li TH; Yun H; Ai HW; Zhang KH
Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-216b targets
Liu T; Ye P; Ye Y; Han B
Int J Biol Sci; 2021; 17(11):2970-2983. PubMed ID: 34345220
[TBL] [Abstract][Full Text] [Related]
15. miR-496 remedies hypoxia reoxygenation-induced H9c2 cardiomyocyte apoptosis via Hook3-targeted PI3k/Akt/mTOR signaling pathway activation.
Jin Y; Ni S
J Cell Biochem; 2020 Jan; 121(1):698-712. PubMed ID: 31436348
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2).
Li N; Han M; Zhou N; Tang Y; Tang XS
Med Sci Monit; 2018 Aug; 24():5960-5972. PubMed ID: 30147110
[TBL] [Abstract][Full Text] [Related]
17. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
18. Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC.
Cui J; Wang J; Shen Y; Lin D
Genes Genomics; 2021 Feb; 43(2):105-114. PubMed ID: 33460027
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-3196 suppresses cell proliferation and induces cell apoptosis through targeting ERBB3 in breast cancer.
Ji ZC; Han SH; Xing YF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8383-8390. PubMed ID: 30556879
[TBL] [Abstract][Full Text] [Related]
20. MiR-200c promotes proliferation of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
Ren ZF; Du MF; Fu H; Liu J; Xia FY; Du HN; Liu N
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5512-5518. PubMed ID: 32495886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]